Scopus BioPharma Inc (SCPS)
0.0011
0.00 (0.00%)
USD |
OTCM |
May 17, 14:00
Scopus BioPharma Free Cash Flow (Quarterly): -1.009M for June 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -1.009M |
| March 31, 2023 | -0.7599M |
| December 31, 2022 | -0.4219M |
| September 30, 2022 | -0.8517M |
| June 30, 2022 | -2.876M |
| March 31, 2022 | -3.979M |
| December 31, 2021 | -4.149M |
| September 30, 2021 | -2.519M |
| June 30, 2021 | -1.962M |
| March 31, 2021 | -2.797M |
| Date | Value |
|---|---|
| December 31, 2020 | -0.9193M |
| September 30, 2020 | -0.6611M |
| June 30, 2020 | -0.8182M |
| March 31, 2020 | -0.1267M |
| December 31, 2019 | -0.6064M |
| September 30, 2019 | -0.603M |
| June 30, 2019 | -0.627M |
| March 31, 2019 | -0.2883M |
| June 30, 2018 | -0.1117M |
| March 31, 2018 | -0.2109M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-4.149M
Minimum
Dec 2021
-0.1267M
Maximum
Mar 2020
-1.511M
Average
-0.8517M
Median
Sep 2022
Free Cash Flow (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -1.574M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -4.881M |
| Oragenics Inc | -1.102M |